Search

Hadush Negash,1 Miglas Welay,2 Haftom Legese,1 Gebre Adhanom,1 Fitsum Mardu,3 Kebede Tesfay,3 Aderajew Gebrewahd,1 Brhane Berhe3 1Unit of Medical Microbiology, Department of Medical Laboratory Sciences, College of Medicine and Health Sciences, Adigrat University, Tigrai, Ethiopia; 2Department of Midwifery, College of Medicine and Health Sciences, Adigrat University, Tigrai, Ethiopia; 3Unit of Medical Parasitology, Department of Medical Laboratory Sciences, College of Medicine and Health Sciences, Adigrat University, Tigrai, EthiopiaCorrespondence: Hadush Negash Email hadunegash@gmail.comBackground: In Ethiopia, despite the integrated implementation of antiretroviral therapy since 2005, the human immunodeficiency virus remains a public health concern. Managing and detecting antiretroviral treatment response is important to monitor the effectiveness of the therapy for individuals who experience failed virological response. An increased viral load indicating drug resistance or rapid progression of viral replication needs early detection. Hence, we aimed to assess the prevalence and determinants of virological response among human immunodeficiency virus-infected patients on highly active antiretroviral therapy.Methods: A hospital-based cross-sectional study was conducted in Adigrat General Hospital from September to December, 2019, on a total of 422 participants. An interviewer-based questionnaire was used for data collection. About 4 mL of venous blood was collected for viral load determination. Patient records were reviewed for the previous results of CD4+ T cell counts. STATA 14 software was used to analyze the data. Descriptive data were presented using tables and figures. Bivariate and multivariate analyses were performed. A p-value < 0.05 was considered a statistically significant association.Results: The mean age of study participants was 39 years (SD ± 12.2 years), of which 66.7% of them were females. The overall prevalence of virological failu

Brhane Tesfanchal,1 Gebremedhin Gebremichail,2 Getachew Belay,1 Gebreslassie Gebremariam,3 Gebreyohannes Teklehaimanot,4 Hagos Haileslasie,2 Getachew Kahsu,1 Aderajew Gebrewahd,5 Fitsum Mardu,6 Gebre Adhanom,5 Brhane Berhe,6 Hirut Teame,7 Aster Tsegaye,8 Mistire Wolde9 1Unit of Clinical Chemistry, Department of Medical Laboratory Sciences, College of Medicine and Health Sciences, Adigrat University, Adigrat, Ethiopia; 2Unit of Hematology and Immuno-Hematology, Department of Medical Laboratory Sciences, College of Medicine and Health Sciences, Adigrat University, Adigrat, Ethiopia; 3Unit of Clinical Chemistry, Department of Medical Laboratory Sciences, College of Medicine and Health Sciences, Mekelle University, Mekelle, Ethiopia; 4Unit of Hematology and Immuno-Hematology, Department of Medical Laboratory Sciences, College of Medicine and Health Sciences, Mekelle University, Mekelle, Ethiopia; 5Unit of Medical Microbiology, Department of Medical Laboratory Sciences, College of Medicine and Health Sciences, Adigrat University, Adigrat, Ethiopia; 6Unit of Medical Parasitology and Entomology, Department of Medical Laboratory Science, College of Medicine and Health Science, Adigrat University, Adigrat, Ethiopia; 7Department of Public Health, College of Medicine and Health Sciences, Adigrat University, Adigrat, Ethiopia; 8Unit of Hematology and Immuno-Hematology, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia; 9Unit of Clinical Chemistry, College of Medicine and Health Sciences, Addis Ababa University, Addis Ababa, EthiopiaCorrespondence: Brhane Tesfanchal Tel +251-949604754Email birhanetesfanchal@gmail.comBackground: Visceral leishmaniasis causes alterations of lipid metabolism and it is associated with hypocholesterolemia and severe hypertriglyceridemia. Hepatic dysfunction and life-threatening hepatitis are associated with visceral leishmaniasis. Kidney damage is frequently associated with increased morbidity and mortality in visceral leishma